/ /

  • linkedin
  • Increase Font
  • Sharebar

    What you need to know about the Essilor-Luxottica deal

     

    Dr. Rogoff says each company likely has a lot of waste that it will be able to eliminate when they finally integrate—meaning big savings for the parent company.

    “If you look at the pattern in the way Essilor purchased Vision Source, PERC, and other types of businesses,” he says, “they operate independently for a long time until Essilor or the parent company starts to figure out how they could lower their expenses by combining certain infrastructure and getting the vertical integration paired correctly.”

    Vision Source and EyeMed

    As with Essilor’s acquisition of Vision Source in 2015, optometrists worry that Vision Source member doctors will be required to use the company’s products.

    Dr. Purcell says Essilor has not required Vision Source ODs to use Essilor products, and he does not anticipate any change in policies due to the deal at this time.

    Related: What the Essilor-Vision Source deal means for you

    “We have kept choice, including our competitors,” he says. “We have demonstrated we can do this, even going back 10 years to when Essilor bought its first labs. Look at the history. We have done what we said.”

    Vision Source administrator and Optometry Times Editorial Advisory Board member Scott Schachter, OD, sees the deal as a boost to Vision Source.

    “We are now part of a bigger team with more power and resources and an eye on the future in a rapidly evolving marketplace,” he says. “In the eyecare world of 2017, I believe it is more important than ever to be part of a team invested in your success.”

    As for EyeMed? Dr. Purcell says he recognizes that the area of managed care is an emotional one for eyecare providers—but it’s just too early in the deal to give any specifics.

    Related: Why you should offer children’s eyewear

    While he says he can’t promise the company will be able to address everything ODs don’t like about EyeMed, Dr. Purcell says that Essilor now has a say and will use the opportunity to voice its customers’ opinions.

    “We have a voice now we didn’t have before,” he says. “The holding company has created a board and it is equal in terms of its voting rights. So we have an equal voice in trying to influence things that people liked as well as didn’t like.”

     

    Colleen E. McCarthy
    Colleen McCarthy is a freelance writer based in the Cleveland area and a former editor of Optometry Times. She is a 2010 graduate of the ...

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V